PineBridge Investments, L.P. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 201 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
PineBridge Investments, L.P. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$14,997
-98.7%
208
-95.2%
0.00%
-100.0%
Q3 2018$1,195,000
+66.7%
4,354
+25.8%
0.02%
+27.8%
Q2 2018$717,000
+19.5%
3,460
-4.7%
0.02%
+28.6%
Q1 2018$600,000
-42.8%
3,632
-52.6%
0.01%
-48.1%
Q4 2017$1,049,000
+197.2%
7,656
+194.9%
0.03%
+237.5%
Q3 2017$353,000
+16.1%
2,596
+3.5%
0.01%0.0%
Q2 2017$304,000
+16.0%
2,508
+1.3%
0.01%
+14.3%
Q1 2017$262,000
+4.4%
2,476
+0.4%
0.01%0.0%
Q4 2016$251,000
+2.0%
2,467
+2.2%
0.01%
-36.4%
Q3 2016$246,000
-14.0%
2,413
+0.4%
0.01%
-26.7%
Q2 2016$286,000
+20.7%
2,403
+8.5%
0.02%
+25.0%
Q1 2016$237,000
-10.2%
2,215
-9.0%
0.01%
+9.1%
Q4 2015$264,000
+36.1%
2,434
+7.0%
0.01%
+37.5%
Q3 2015$194,000
-6.7%
2,275
+10.3%
0.01%0.0%
Q2 2015$208,000
-41.6%
2,062
-55.3%
0.01%
-38.5%
Q1 2015$356,000
+63.3%
4,614
+12.5%
0.01%
+62.5%
Q4 2014$218,000
+13.5%
4,102
+0.4%
0.01%0.0%
Q3 2014$192,000
-5.0%
4,084
+26.0%
0.01%0.0%
Q2 2014$202,000
-41.3%
3,241
-36.6%
0.01%
-27.3%
Q1 2014$344,000
+16.6%
5,112
-8.7%
0.01%
+22.2%
Q4 2013$295,0005,6000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders